{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:46:59Z","timestamp":1785163619165,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.radonc.2013.08.002","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T13:04:39Z","timestamp":1378559079000},"page":"146-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: Correlation with outcomes following chemo-radiotherapy"],"prefix":"10.1016","volume":"109","author":[{"given":"Duncan C","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Stokoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Linsdall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles MH","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2013.08.002_b0005","article-title":"Incidence rates for anal cancer in the United States: 1980\u20132009","volume":"30","author":"Eberly","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2013.08.002_b0010","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98\u201311 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2013.08.002_b0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2013.08.002_b0020","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1245\/s10434-007-9491-8","article-title":"Outcomes of salvage surgery for squamous cell carcinoma of the anal canal","volume":"14","author":"Schiller","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2013.08.002_b0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"Zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0030","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2013.08.002_b0035","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.clon.2011.05.007","article-title":"Clinically significant human papilloma virus in squamous cell carcinoma of the head and neck in UK practice","volume":"24","author":"Heath","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2013.08.002_b0040","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1158\/1078-0432.CCR-11-0388","article-title":"Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination","volume":"17","author":"Schache","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2013.08.002_b0045","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2013.08.002_b0050","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/ijc.25825","article-title":"The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy","volume":"129","author":"Yhim","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0055","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.bjc.6604285","article-title":"Gene expression reveals two distinct groups of anal carcinomas with clinical implications","volume":"98","author":"Bruland","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0065","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/bjc.2012.109","article-title":"The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer","volume":"106","author":"Lajer","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0070","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/1078-0432.CCR-07-1402","article-title":"Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck","volume":"14","author":"Westra","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2013.08.002_b0075","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.ejca.2006.01.056","article-title":"Molecular prognostic markers in resectable colorectal liver metastases: a systematic review","volume":"42","author":"Neal","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0080","first-page":"6489","article-title":"Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma","volume":"9","author":"Allal","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2013.08.002_b0085","article-title":"The role of biological molecular markers in predicting both response to treatment and clinical outcome in squamous cell carcinoma of the anus","author":"Mawdsley","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2013.08.002_b0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0360-3016(99)00188-1","article-title":"Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal","volume":"45","author":"Wong","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.08.002_b0095","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.bjc.6605984","article-title":"Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review","volume":"103","author":"Lampejo","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2009.02.015","article-title":"The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas","volume":"74","author":"Kong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.08.002_b0105","doi-asserted-by":"crossref","first-page":"e17517","DOI":"10.1371\/journal.pone.0017517","article-title":"Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas","volume":"6","author":"Stankiewicz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2013.08.002_b0110","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2013.08.002_b0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1749-4486.2006.01246.x","article-title":"Human papillomavirus and head and neck cancer: a systematic review and meta-analysis","volume":"31","author":"Hobbs","year":"2006","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.radonc.2013.08.002_b0120","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.radonc.2013.08.002_b0125","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cncr.27825","article-title":"Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I)","volume":"119","author":"Glynne-Jones","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2013.08.002_b0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000259615","article-title":"Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status","volume":"77","author":"Lukan","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.radonc.2013.08.002_b0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1471-2407-10-189","article-title":"Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas","volume":"10","author":"Van Damme","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00280-009-1117-3","article-title":"K-ras status in squamous cell anal carcinoma (SCC): it\u2019s time for target-oriented treatment?","volume":"65","author":"Zampino","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.radonc.2013.08.002_b0150","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/bjc.2012.479","article-title":"EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?","volume":"107","author":"Paliga","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2013.08.002_b0155","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.4098","article-title":"Cetuximab plus radiochemotherapy in locally advanced anal cancer: Interim results of the French multicenter phase II trial ACCORD16","volume":"29","author":"Deutsch","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2013.08.002_b0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1091-255X(01)80066-4","article-title":"Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy","volume":"5","author":"van der Wal","year":"2001","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.radonc.2013.08.002_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/codi.12222","article-title":"Outcome of salvage surgery for anal squamous cell carcinoma","author":"Harris","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.radonc.2013.08.002_b0170","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.2011.40.4848","article-title":"Epidermal growth factor receptor and the changing face of oropharyngeal cancer","volume":"30","author":"Gilbert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2013.08.002_b0175","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1470-2045(13)70181-5","article-title":"Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial","volume":"14","author":"Vermorken","year":"2013","journal-title":"Lancet Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814013003745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814013003745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T15:50:05Z","timestamp":1563897005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814013003745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0167814013003745"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2013.08.002","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: Correlation with outcomes following chemo-radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2013.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}